Figshareopen access
Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumab
biomedical and clinical sciences, cardiovascular medicine and haematology, clinical sciences, pharmacology and pharmaceutical sciences, immune thrombocytopenia, itp, daratumumab, anti-cd38
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 268283
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.